Diabetes Limits Stem Cell Mobilization Following G-CSF but Not Plerixafor

Previous studies suggest that diabetes impairs hematopoietic stem cell (HSC) mobilization in response to granulocyte colony-stimulating factor (G-CSF). In this study, we tested whether the CXCR4 antagonist plerixafor, differently from G-CSF, is effective in mobilizing HSCs in patients with diabetes....

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Diabetes
Autors principals: Fadini, Gian Paolo, Fiala, Mark, Cappellari, Roberta, Danna, Marianna, Park, Soo, Poncina, Nicol, Menegazzo, Lisa, Albiero, Mattia, DiPersio, John, Stockerl-Goldstein, Keith, Avogaro, Angelo
Format: Artigo
Idioma:Inglês
Publicat: American Diabetes Association 2015
Matèries:
Complications
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4512229/
https://ncbi.nlm.nih.gov/pubmed/25804941
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db15-0077
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars